Menstrual cycle hormone changes in women traversing menopause

Study of women's health across the nation

Nanette Santoro, Sybil L. Crawford, Samar R. El Khoudary, Amanda A. Allshouse, Sherri Ann Burnett-Bowie, Joel Finkelstein, Carol A. Derby, Karen Matthews, Howard M. Kravitz, Sioban D. Harlow, Gail A. Greendale, Ellen B. Gold, Rasa Kazlauskaite, Dan McConnell, Genevieve Neal-Perry, Jelena M. Pavlovic, John Randolph, Gerson Weiss, Hsiang Yu Chen, Bill Lasley

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context: Menstrual cycle hormone patterns in women approaching menopause are inadequately studied. Objective: To describe day-to-day menstrual cycle hormones in women as they approach menopause from the Study of Women's Health Across the Nation Daily Hormone Study (DHS). Design: DHS enrollees collected daily urine for one entire menstrual cycle or up to 50 days, whichever came first, annually, up to the final menstrual period (FMP) or for up to 10 years. Setting: Seven sites across the United States. Participants: A total of 511 premenopausal or early perimenopausal women at enrollment, within 10 years before menopause. Intervention: Time-to-FMP measurement. Main Outcome Measures: Evidence of luteal activity (ELA), determined using objective algorithms. Menstrual cycle/segment length; whole cycle, and segment integrated urinary luteinizing hormone, follicle-stimulating hormone, estrone conjugates, and pregnanediol glucuronide (Pdg) for each year, organized around the FMP. Results: Mean menstrual cycle length was remarkably preserved at 26 to 27 days in ELA cycles; non-ELA cycles had greater variability. The percentage of cycles that were ELA remained high until 5 years before the FMP (87.9%); only 22.8% of cycles within 1 year of the FMP were ELA. Whole cycle hormones remained relatively stable up to 3 years before the FMP, when gonadotropins began to increase. Pdg excretion declined slowly with progress to the FMP, but Pdg patterns of ELA cycles remained distinguishable from non-ELA. Conclusions: Menstrual cycle hormone patterns in perimenopausal women resemble those of midreproductive-aged women until 5 years before menopause, and presumably ovulatory cycles retain a potentially fertile pattern up to the end of reproductive life.

Original languageEnglish (US)
Pages (from-to)2218-2229
Number of pages12
JournalJournal of Clinical Endocrinology and Metabolism
Volume102
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Corpus Luteum
Women's Health
Menstrual Cycle
Menopause
Pregnanediol
Hormones
Activity Cycles
Glucuronides
Estrone
Follicle Stimulating Hormone
Luteinizing Hormone
Gonadotropins
Outcome Assessment (Health Care)
Urine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Santoro, N., Crawford, S. L., El Khoudary, S. R., Allshouse, A. A., Burnett-Bowie, S. A., Finkelstein, J., ... Lasley, B. (2017). Menstrual cycle hormone changes in women traversing menopause: Study of women's health across the nation. Journal of Clinical Endocrinology and Metabolism, 102(7), 2218-2229. https://doi.org/10.1210/jc.2016-4017

Menstrual cycle hormone changes in women traversing menopause : Study of women's health across the nation. / Santoro, Nanette; Crawford, Sybil L.; El Khoudary, Samar R.; Allshouse, Amanda A.; Burnett-Bowie, Sherri Ann; Finkelstein, Joel; Derby, Carol A.; Matthews, Karen; Kravitz, Howard M.; Harlow, Sioban D.; Greendale, Gail A.; Gold, Ellen B.; Kazlauskaite, Rasa; McConnell, Dan; Neal-Perry, Genevieve; Pavlovic, Jelena M.; Randolph, John; Weiss, Gerson; Chen, Hsiang Yu; Lasley, Bill.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 102, No. 7, 01.07.2017, p. 2218-2229.

Research output: Contribution to journalArticle

Santoro, N, Crawford, SL, El Khoudary, SR, Allshouse, AA, Burnett-Bowie, SA, Finkelstein, J, Derby, CA, Matthews, K, Kravitz, HM, Harlow, SD, Greendale, GA, Gold, EB, Kazlauskaite, R, McConnell, D, Neal-Perry, G, Pavlovic, JM, Randolph, J, Weiss, G, Chen, HY & Lasley, B 2017, 'Menstrual cycle hormone changes in women traversing menopause: Study of women's health across the nation', Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 7, pp. 2218-2229. https://doi.org/10.1210/jc.2016-4017
Santoro N, Crawford SL, El Khoudary SR, Allshouse AA, Burnett-Bowie SA, Finkelstein J et al. Menstrual cycle hormone changes in women traversing menopause: Study of women's health across the nation. Journal of Clinical Endocrinology and Metabolism. 2017 Jul 1;102(7):2218-2229. https://doi.org/10.1210/jc.2016-4017
Santoro, Nanette ; Crawford, Sybil L. ; El Khoudary, Samar R. ; Allshouse, Amanda A. ; Burnett-Bowie, Sherri Ann ; Finkelstein, Joel ; Derby, Carol A. ; Matthews, Karen ; Kravitz, Howard M. ; Harlow, Sioban D. ; Greendale, Gail A. ; Gold, Ellen B. ; Kazlauskaite, Rasa ; McConnell, Dan ; Neal-Perry, Genevieve ; Pavlovic, Jelena M. ; Randolph, John ; Weiss, Gerson ; Chen, Hsiang Yu ; Lasley, Bill. / Menstrual cycle hormone changes in women traversing menopause : Study of women's health across the nation. In: Journal of Clinical Endocrinology and Metabolism. 2017 ; Vol. 102, No. 7. pp. 2218-2229.
@article{288e4a2e666242c8ba6b0aa74c175b8d,
title = "Menstrual cycle hormone changes in women traversing menopause: Study of women's health across the nation",
abstract = "Context: Menstrual cycle hormone patterns in women approaching menopause are inadequately studied. Objective: To describe day-to-day menstrual cycle hormones in women as they approach menopause from the Study of Women's Health Across the Nation Daily Hormone Study (DHS). Design: DHS enrollees collected daily urine for one entire menstrual cycle or up to 50 days, whichever came first, annually, up to the final menstrual period (FMP) or for up to 10 years. Setting: Seven sites across the United States. Participants: A total of 511 premenopausal or early perimenopausal women at enrollment, within 10 years before menopause. Intervention: Time-to-FMP measurement. Main Outcome Measures: Evidence of luteal activity (ELA), determined using objective algorithms. Menstrual cycle/segment length; whole cycle, and segment integrated urinary luteinizing hormone, follicle-stimulating hormone, estrone conjugates, and pregnanediol glucuronide (Pdg) for each year, organized around the FMP. Results: Mean menstrual cycle length was remarkably preserved at 26 to 27 days in ELA cycles; non-ELA cycles had greater variability. The percentage of cycles that were ELA remained high until 5 years before the FMP (87.9{\%}); only 22.8{\%} of cycles within 1 year of the FMP were ELA. Whole cycle hormones remained relatively stable up to 3 years before the FMP, when gonadotropins began to increase. Pdg excretion declined slowly with progress to the FMP, but Pdg patterns of ELA cycles remained distinguishable from non-ELA. Conclusions: Menstrual cycle hormone patterns in perimenopausal women resemble those of midreproductive-aged women until 5 years before menopause, and presumably ovulatory cycles retain a potentially fertile pattern up to the end of reproductive life.",
author = "Nanette Santoro and Crawford, {Sybil L.} and {El Khoudary}, {Samar R.} and Allshouse, {Amanda A.} and Burnett-Bowie, {Sherri Ann} and Joel Finkelstein and Derby, {Carol A.} and Karen Matthews and Kravitz, {Howard M.} and Harlow, {Sioban D.} and Greendale, {Gail A.} and Gold, {Ellen B.} and Rasa Kazlauskaite and Dan McConnell and Genevieve Neal-Perry and Pavlovic, {Jelena M.} and John Randolph and Gerson Weiss and Chen, {Hsiang Yu} and Bill Lasley",
year = "2017",
month = "7",
day = "1",
doi = "10.1210/jc.2016-4017",
language = "English (US)",
volume = "102",
pages = "2218--2229",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Menstrual cycle hormone changes in women traversing menopause

T2 - Study of women's health across the nation

AU - Santoro, Nanette

AU - Crawford, Sybil L.

AU - El Khoudary, Samar R.

AU - Allshouse, Amanda A.

AU - Burnett-Bowie, Sherri Ann

AU - Finkelstein, Joel

AU - Derby, Carol A.

AU - Matthews, Karen

AU - Kravitz, Howard M.

AU - Harlow, Sioban D.

AU - Greendale, Gail A.

AU - Gold, Ellen B.

AU - Kazlauskaite, Rasa

AU - McConnell, Dan

AU - Neal-Perry, Genevieve

AU - Pavlovic, Jelena M.

AU - Randolph, John

AU - Weiss, Gerson

AU - Chen, Hsiang Yu

AU - Lasley, Bill

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Context: Menstrual cycle hormone patterns in women approaching menopause are inadequately studied. Objective: To describe day-to-day menstrual cycle hormones in women as they approach menopause from the Study of Women's Health Across the Nation Daily Hormone Study (DHS). Design: DHS enrollees collected daily urine for one entire menstrual cycle or up to 50 days, whichever came first, annually, up to the final menstrual period (FMP) or for up to 10 years. Setting: Seven sites across the United States. Participants: A total of 511 premenopausal or early perimenopausal women at enrollment, within 10 years before menopause. Intervention: Time-to-FMP measurement. Main Outcome Measures: Evidence of luteal activity (ELA), determined using objective algorithms. Menstrual cycle/segment length; whole cycle, and segment integrated urinary luteinizing hormone, follicle-stimulating hormone, estrone conjugates, and pregnanediol glucuronide (Pdg) for each year, organized around the FMP. Results: Mean menstrual cycle length was remarkably preserved at 26 to 27 days in ELA cycles; non-ELA cycles had greater variability. The percentage of cycles that were ELA remained high until 5 years before the FMP (87.9%); only 22.8% of cycles within 1 year of the FMP were ELA. Whole cycle hormones remained relatively stable up to 3 years before the FMP, when gonadotropins began to increase. Pdg excretion declined slowly with progress to the FMP, but Pdg patterns of ELA cycles remained distinguishable from non-ELA. Conclusions: Menstrual cycle hormone patterns in perimenopausal women resemble those of midreproductive-aged women until 5 years before menopause, and presumably ovulatory cycles retain a potentially fertile pattern up to the end of reproductive life.

AB - Context: Menstrual cycle hormone patterns in women approaching menopause are inadequately studied. Objective: To describe day-to-day menstrual cycle hormones in women as they approach menopause from the Study of Women's Health Across the Nation Daily Hormone Study (DHS). Design: DHS enrollees collected daily urine for one entire menstrual cycle or up to 50 days, whichever came first, annually, up to the final menstrual period (FMP) or for up to 10 years. Setting: Seven sites across the United States. Participants: A total of 511 premenopausal or early perimenopausal women at enrollment, within 10 years before menopause. Intervention: Time-to-FMP measurement. Main Outcome Measures: Evidence of luteal activity (ELA), determined using objective algorithms. Menstrual cycle/segment length; whole cycle, and segment integrated urinary luteinizing hormone, follicle-stimulating hormone, estrone conjugates, and pregnanediol glucuronide (Pdg) for each year, organized around the FMP. Results: Mean menstrual cycle length was remarkably preserved at 26 to 27 days in ELA cycles; non-ELA cycles had greater variability. The percentage of cycles that were ELA remained high until 5 years before the FMP (87.9%); only 22.8% of cycles within 1 year of the FMP were ELA. Whole cycle hormones remained relatively stable up to 3 years before the FMP, when gonadotropins began to increase. Pdg excretion declined slowly with progress to the FMP, but Pdg patterns of ELA cycles remained distinguishable from non-ELA. Conclusions: Menstrual cycle hormone patterns in perimenopausal women resemble those of midreproductive-aged women until 5 years before menopause, and presumably ovulatory cycles retain a potentially fertile pattern up to the end of reproductive life.

UR - http://www.scopus.com/inward/record.url?scp=85023182379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023182379&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-4017

DO - 10.1210/jc.2016-4017

M3 - Article

VL - 102

SP - 2218

EP - 2229

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -